Milestone Pharmaceuticals Inc. Increase (Decrease) in Income Taxes
Milestone Pharmaceuticals Inc. (MIST) reported Increase (Decrease) in Income Taxes of -$56.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxes · last filed 2021-03-29
- Milestone Pharmaceuticals Inc. increase (decrease) in income taxes for the quarter ending 2019-12-31 was -$1.00K, a 101.79% decline year-over-year.
- Milestone Pharmaceuticals Inc. increase (decrease) in income taxes for the quarter ending 2019-09-30 was $1.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in income taxes for the quarter ending 2019-06-30 was -$78.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in income taxes for the quarter ending 2019-03-31 was $22.00K, a 37.50% increase year-over-year.
- Milestone Pharmaceuticals Inc. increase (decrease) in income taxes for fiscal 2019 was -$56.00K, a 207.69% decline from fiscal 2018.
- Milestone Pharmaceuticals Inc. increase (decrease) in income taxes for fiscal 2018 was $52.00K.
| Period end | Increase (Decrease) in Income Taxes 3 month | Increase (Decrease) in Income Taxes 6 month | Increase (Decrease) in Income Taxes 9 month | Increase (Decrease) in Income Taxes 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | -$78.00K derived: sum of 3 quarters · filed 2021-03-29 | -$56.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$77.00K derived: sum of 2 quarters · filed 2020-11-13 | -$55.00K 10-Q · filed 2020-11-13 | $1.00K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$56.00K 10-Q · filed 2020-08-12 | $0.00 derived: sum of 3 quarters · filed 2020-10-23 | $0.00 derived: sum of 4 quarters · filed 2020-10-23 |
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-14 | $78.00K derived: sum of 2 quarters · filed 2020-10-23 | $78.00K derived: sum of 3 quarters · filed 2020-10-23 | $58.00K derived: sum of 4 quarters · filed 2020-10-23 |
| 2018-12-31 | $56.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-10-23 | $56.00K derived: sum of 2 quarters · filed 2020-10-23 | $36.00K derived: sum of 3 quarters · filed 2020-10-23 | $52.00K 10-K/A · filed 2020-10-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$20.00K derived: sum of 2 quarters · filed 2019-11-13 | -$4.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$4.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $16.00K 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |